<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00620529</url>
  </required_header>
  <id_info>
    <org_study_id>EC 2008/049</org_study_id>
    <nct_id>NCT00620529</nct_id>
  </id_info>
  <brief_title>The Effects of Fish Oils on Blood Pressure, Heart Rate Variability and Liver Fat in the Polycystic Ovary Syndrome</brief_title>
  <acronym>fops</acronym>
  <official_title>A Clinical Trial to Measure the Effect of DHA-enriched Fish Oils on Blood Pressure, Heart Rate Variability and Liver Fat Content in the Polycystic Ovary Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Keogh Institute for Medical Research</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Royal Perth Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Keogh Institute for Medical Research</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We hypothesise that fish oils will have a beneficial effect on cardiometabolic parameters in
      women with PCOS. The purpose of this study therefore is to examine the effects of fish oils
      on blood pressure, heart rate variability and liver fat content in obese women with the
      polycystic ovary syndrome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The prevalence of abnormalities of blood pressure (ABP), variability of heart rate (HRV) and
      liver fat content is increased in women with the polycystic ovary syndrome (PCOS). We
      hypothesise that fish oils will have a beneficial effect on these endpoints and other
      cardiometabolic parameters such as cholesterol and liver function in women with PCOS. This
      crossover study of 40 obese women with PCOS will therefore examine the effects of fish oils
      on the above parameters compared with placebo (olive oil). Subjects with PCOS who have
      participated in previous studies with this research group will be approached for recruitment,
      as will eligible subjects within the endocrine clinics of the chief and co-investigators.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2008</start_date>
  <completion_date type="Actual">February 2009</completion_date>
  <primary_completion_date type="Actual">December 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>24 hour ambulatory systolic blood pressure</measure>
    <time_frame>week 8 and week 24</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>24 hour heart rate variability</measure>
    <time_frame>week 8 and week 24</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>liver fat content (MRI)</measure>
    <time_frame>week 8 and week 24</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Polycystic Ovary Syndrome</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>20/50 fish oil, 1000mg capsules, Ocean Nutrition 2050,4g/day.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>olive oil capsules</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Ocean Nutrition 2050</intervention_name>
    <description>1000mg capsules, 4 capsules/day for 8 weeks</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Code name: 2050</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Olive oil capsules</intervention_name>
    <description>Olive oil capsules, 4 per day for 8 weeks</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Overweight/obese women with PCOS as per 1990 NIH criteria (see below)

          -  Non-smokers

          -  Age&gt;18 years, premenopausal

          -  Acceptable to have/be on treatment for type 2 diabetes mellitus and/or dyslipidaemia

          -  Acceptable to be taking the oral contraceptive pill

        Exclusion Criteria:

          -  Uncontrolled hypertension (BP&gt;160/100mmHg)

          -  Known co-morbidities including liver or renal disease

          -  Already taking fish oil supplements

          -  Other intercurrent illness (major surgery, CV event)

          -  Smokers

          -  Alcohol intake &gt;20g/day

          -  Pregnancy

          -  Any metallic implant (contraindication for MRI).
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrea J Cussons, MBBS</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Western Australia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>School of Medicine and Pharmacology, Royal Perth Hospital</name>
      <address>
        <city>Perth</city>
        <state>Western Australia</state>
        <zip>6000</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
  </location_countries>
  <verification_date>January 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 11, 2008</study_first_submitted>
  <study_first_submitted_qc>February 20, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 21, 2008</study_first_posted>
  <last_update_submitted>January 31, 2010</last_update_submitted>
  <last_update_submitted_qc>January 31, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 2, 2010</last_update_posted>
  <responsible_party>
    <name_title>Dr Andrea Cussons</name_title>
    <organization>University of Western Australia</organization>
  </responsible_party>
  <keyword>polycystic ovary syndrome</keyword>
  <keyword>cardiovascular risk</keyword>
  <keyword>metabolism</keyword>
  <keyword>blood pressure</keyword>
  <keyword>liver fat</keyword>
  <keyword>heart rate variability</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Polycystic Ovary Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

